Wednesday, August 12, 2026
News Health

News Health

A phase 3 trial compares first-line fixed-duration venetoclax-obinutuzumab to fludarabine, cyclophosphamide, and rituximab/bendamustine-rituximab in patients with CLL. Medscape Medical News Source link : https://www.medscape.com/viewarticle/venetoclax-obinutuzumab-boosts-mrd-clearance-cll-2026a1000mqf?src=rss Author : Publish date : 2026-07-06...

Read more
Page 21 of 116 1 20 21 22 116

Categories

Archives

August 2026
MTWTFSS
 12
3456789
10111213141516
17181920212223
24252627282930
31